WFMPM
SRNE

Woodley Farra Manion Portfolio Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Woodley Farra Manion Portfolio Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,000
Closed -$6K – 429
2020
Q2 		$6K Buy
+1,000
New +$3.83K ﹤0.01% 315

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Woodley Farra Manion Portfolio Management's SRNE Position: Q3 2020 in Review

Woodley Farra Manion Portfolio Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2020, closing a stake of 1,000 shares — an estimated $6K sold.

Woodley Farra Manion Portfolio Management first reported a position in SRNE in Q2 2020 and held it in 1 quarter. The position peaked at $6K in Q2 2020. 209 funds tracked by Wall St. Rank hold SRNE as of Q3 2020.

  • Woodley Farra Manion Portfolio Management reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Woodley Farra Manion Portfolio Management sold 1,000 Sorrento Therapeutics, Inc. shares in Q3 2020, an estimated $6K.
  • Woodley Farra Manion Portfolio Management first reported a position in Sorrento Therapeutics, Inc. in Q2 2020 and held it in 1 quarter.
  • Woodley Farra Manion Portfolio Management's Sorrento Therapeutics, Inc. position peaked at $6K in Q2 2020.
  • 209 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2020.

Based on Woodley Farra Manion Portfolio Management's 13F filing for Q3 2020, filed 5 Nov 2020.